The FDA rolls out its own AI to speed up clinical reviews and scientific evaluations

The FDA has launched the generative AI tool, Elsa, agency-wide. Elsa completed a "very successful pilot program with FDAs scientific reviewers" It's already being used to speed up clinical protocol reviews and scientific evaluations.